CLINICAL_TRIALS
trial_result
· 2021-01-29
Clinical Trial Update: Nintedanib and Weekly Docetaxel in Lung Adenocarcinoma [Phase 1]
Summary
Phase 1 trial update evaluating nintedanib with weekly docetaxel in non-small cell lung cancer.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 1 | Status: COMPLETED | Results posted: 2021-01-29